Cannabinoids for epilepsy: What do we know and where do we go?

Pharmacology of cannabinoids in the treatment of epilepsy

(2017) Tyler E. Gaston et al.   EPILEPSY & BEHAVIOR

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

(2017) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome

(2017) Emma H. Kaplan et al.   PEDIATRIC NEUROLOGY

Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol

(2016) Reesha R. Patel et al.   BRAIN

Cannabinoids and Cytochrome P450 Interactions

(2016) Ondřej Zendulka et al.   CURRENT DRUG METABOLISM

Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex

(2016) Evan J. Hess et al.   EPILEPSIA

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

(2016) Orrin Devinsky et al.   LANCET NEUROLOGY

CBD-enriched medical cannabis for intractable pediatric epilepsy

(2016) Michal Tzadok et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy

(2015) Alexandra L. Geffrey et al.   EPILEPSIA

Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome

(2015) Shaun A. Hussain et al.   EPILEPSY & BEHAVIOR

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy

(2015) Craig A. Press et al.   EPILEPSY & BEHAVIOR

Cannabinoids: is there a potential treatment role in epilepsy?

(2015) Robert E Blair et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cannabinoids and Epilepsy

(2015) Evan C. Rosenberg et al.   Neurotherapeutics

Molecular Targets of Cannabidiol in Neurological Disorders

(2015) Clementino Ibeas Bih et al.   Neurotherapeutics

Cannabinoids in the Treatment of Epilepsy

(2015) Daniel Friedman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability

(2014) Fabio Arturo Iannotti et al.   ACS Chemical Neuroscience

The case for medical marijuana in epilepsy

(2014) Edward Maa et al.   EPILEPSIA

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

(2014) Orrin Devinsky et al.   EPILEPSIA

Phytocannabinoids and epilepsy

(2014) R. G. dos Santos et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

(2013) Stephen M. Stout et al.   DRUG METABOLISM REVIEWS

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy

(2013) Brenda E. Porter et al.   EPILEPSY & BEHAVIOR

Cannabinoids

(2013) Paul Howard et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Cannabidivarin is anticonvulsant in mouse and rat

(2012) AJ Hill et al.   BRITISH JOURNAL OF PHARMACOLOGY

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain

(2012) Bernard P. Roques et al.   NATURE REVIEWS DRUG DISCOVERY

CB2: a cannabinoid receptor with an identity crisis

(2010) Brady K Atwood et al.   BRITISH JOURNAL OF PHARMACOLOGY